Stock analysis, trade plans, and proprietary indicators by Trend Edge.
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials s… Read full Trend Edge analysis →
| Current Price | $13.24 |
|---|---|
| Market Cap | $921M |
| Float | 57.7M |
| Shares Outstanding | 65.6M |
| Price/Sales (TTM) | 3.61 |
| vs. Analyst Target | +57.7% to analyst PT |
| Profit Margin | -40.60% |
| Operating Margin (TTM) | -83.29% |
| Revenue (TTM) | $255M |
| Dividend Rate | None |
| Analyst Target Price | $20.88 (8 analysts) |
| Year | Revenue | Net Income | Gross Profit | EBITDA |
|---|---|---|---|---|
| 2020 | $108M | -$24.5M | $63.5M | -$57.3M |
| 2021 | $138M | -$100M | $65.6M | -$109M |
| 2022 | $181M | -$149M | $101M | -$142M |
| 2023 | $217M | $40.7M | $141M | -$172M |
| 2024 | $208M | -$187M | $132M | -$203M |
| 2025 | $256M | -$103M | $143M | -$96.3M |
| Quarter | Revenue | Net Income |
|---|---|---|
| Jun 2025 | $54.8M | -$43.2M |
| Sep 2025 | $54.3M | -$32.8M |
| Dec 2025 | $87.2M | $32.5M |
| Mar 2026 | $58.6M | -$60.0M |
| Insider Ownership | 2.9% |
|---|---|
| Institutional Ownership | 98.0% |
| Short Float | 18.0% |
| % of All Funds Holding | 2.54% |
| Number of Funds Holding | 209 |
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
| Timeframe | SMA | Value | Trend Context |
|---|---|---|---|
| Weekly | 10-Week SMA | $12.22 | Near-term / short-term trend |
| Weekly | 40-Week SMA | $15.78 | Medium-term trend |
| Weekly | 80-Week SMA | $18.85 | Cyclical trend (business cycle) |
| Weekly | 200-Week SMA | $23.65 | Secular trend (multi-year) |
| Monthly | 10-Month SMA | $15.86 | Near-term monthly trend |
| Monthly | 20-Month SMA | $18.65 | Medium-term monthly trend |
| Monthly | 40-Month SMA | $23.65 | Secular monthly trend |
Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
| Price Level | Type | Volume Ratio | Age |
|---|---|---|---|
| $25.80 | resistance | 1.28x | 11 months ago |
| Timeframe | Avg Return | Median | Win Rate | Best | Worst |
|---|---|---|---|---|---|
| Gap | -0.38% | -1.06% | 46.15% | 22.73% | -21.30% |
| 1 Day | -1.91% | -1.69% | 42.31% | 19.12% | -23.91% |
| 1 Week | -1.00% | -5.29% | 38.46% | 35.91% | -23.75% |
| 2 Weeks | 0.49% | -1.18% | 46.15% | 41.94% | -32.58% |
| 1 Month | 1.93% | -1.86% | 48.00% | 47.05% | -32.56% |
Next earnings: July 24, 2026 (56 days away)
Insufficient historical data for monthly seasonality analysis (requires 7+ years of data).
| Day | Avg Return | Win Rate | Samples |
|---|---|---|---|
| Monday | 0.28% | 50.8% | 295 |
| Tuesday | -0.13% | 45.7% | 328 |
| Wednesday | 0.00% | 48.6% | 325 |
| Thursday | -0.10% | 46.7% | 317 |
| Friday | 0.21% | 47.3% | 317 |
Institutional holder breakdown coming soon.
Total institutional ownership: 98.0%
Total insider ownership: 2.9%
Founder-led management: Richard A. Friesner (Co-Founder, Scientific Advisory Chairman and Director), William A. Goddard III (Co-Founder & Scientific Advisor)
| Total Filings | 16 |
|---|---|
| Net Value | -$895,699.798 |
| Net Shares Change | 225,198 |
| % of Float | 0.4% |
| C-Suite Filings | 16 |
| Clusters Detected | 2 |
| Name | Title | Net Value | Filings | Activity |
|---|---|---|---|---|
| Farid Ramy | President and CEO | -$628,510.322 | 2 | N/A |
| Abel Robert Lorne | EVP, Chief Scientific Officer, Platform | -$33,270.3 | 2 | N/A |
| Jain Rachit | EVP and CFO | -$31,791.844 | 2 | N/A |
| Dugan Margaret | Chief Medical Officer | -$29,387.07 | 1 | N/A |
| Akinsanya Karen | President, Head of Therapeutics RandD and Chief Strategy Officer, Partnerships | -$26,454.352 | 1 | N/A |
| Herman Jenny | CAO | -$17,763.529 | 1 | N/A |
| Tran Yvonne | EVP, CLO and CPO | -$14,107.13 | 1 | N/A |
| Period | Filings | Insiders | Net Value | Seniority |
|---|---|---|---|---|
| 2026-02-11 – 2026-02-12 | 4 | 4 | -$50,396.831 | 4 C-suite |
| 2026-03-03 – 2026-03-06 | 9 | 7 | -$242,798.319 | 9 C-suite |
| Date | Insider | Title | Net Value | Price After |
|---|---|---|---|---|
| 2026-04-17 | Farid Ramy | President and CEO | -$562,359.11 | Transaction at $7.67, now +72.6% |
| 2026-03-03 | Farid Ramy | President and CEO | -$66,151.212 | Transaction at $11.90, now +11.3% |
| 2026-03-03 | Akinsanya Karen | President, Head of Therapeutics RandD and Chief Strategy Officer, Partnerships | -$26,454.352 | Transaction at $11.99, now +10.4% |
| 2026-03-06 | Tran Yvonne | EVP, CLO and CPO | -$14,107.13 | Transaction at $12.89, now +2.7% |
| 2026-03-06 | Jain Rachit | EVP and CFO | -$21,033.376 | Transaction at $12.90, now +2.7% |
| 2026-03-06 | Herman Jenny | CAO | -$17,763.529 | Transaction at $12.84, now +3.1% |
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Schrodinger Inc (SDGR) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.
Get the full AI Consult analysis for SDGR on Trend Edge →